The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune cell repertoire in patients with metastatic renal cell carcinoma: Data from prospective clinical trial.
 
Vijay Damarla
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Laura S. Wood
No Relationships to Disclose
 
Sylvia Sybor
No Relationships to Disclose
 
Pat A. Rayman
No Relationships to Disclose
 
Yu Ning Wong
No Relationships to Disclose
 
Elizabeth R. Plimack
Consulting or Advisory Role - Astellas Pharma; Dendreon; GlaxoSmithKline; Merck; Novartis
Research Funding - Acceleron Pharma; AstraZeneca; Bristol-Myers Squibb; Dendreon; GlaxoSmithKline; Lilly; Merck; Pfizer
Patents, Royalties, Other Intellectual Property - patent pending
 
James Finke
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Millennium (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer